Skip to main content
. 2018 Feb;10(2):1124–1128. doi: 10.21037/jtd.2018.01.79

Figure 1.

Figure 1

Serial imaging before and during immunotherapy in a patient with metastatic squamous cell lung cancer. The primary tumor and mediastinal adenopathy showed stability over several months on standard platinum-based chemotherapy. A dramatic increase in size was noted on surveillance imaging approximately 6 weeks after starting immunotherapy. Repeat biopsy demonstrated poorly differentiated squamous cell carcinoma.